Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yasuaki Kimura is active.

Publication


Featured researches published by Yasuaki Kimura.


Journal of the American Chemical Society | 2009

Two methods for catalytic generation of reactive enolates promoted by a chiral poly gd complex: application to catalytic enantioselective protonation reactions.

Masataka Morita; Ludovic Drouin; Rie Motoki; Yasuaki Kimura; Ikuo Fujimori; Motomu Kanai; Masakatsu Shibasaki

A chiral polynuclear Gd complex derived from Gd(O(i)Pr)(3) and FujiCAPO (2 or 3) catalytically generated Gd enolates through two distinct methods; transmetalation from enol silyl ethers and conjugate addition of cyanide to alpha,beta-unsaturated N-acyl pyrroles. These chiral enolates can be enantioselectively protonated by a proton in an asymmetric environment in the polynuclear catalyst. Thus, catalytic enantioselective protonation of enol silyl ethers was promoted by the Gd catalyst (5-10 mol %) in the presence of a stoichiometric amount of 2,6-dimethylphenol. Kinetic studies and dependencies of the enantioselectivity on the silyl group structure and the proton source suggest that the reaction proceeds through a Gd enolate generated through transmetalation. Moreover, the same Gd complex (5-10 mol %) promoted conjugate addition of a cyanide-enantioselective protonation sequential reaction from alpha,beta-unsaturated N-acyl pyrroles. Because Gd isocyanide was determined to be the active nucleophile in the conjugate addition catalyzed by the Gd complex, enantioselective protonation likely proceeded through a Gd enolate in this case as well. The products are versatile dual functional chiral building blocks for organic synthesis.


British Journal of Pharmacology | 2013

Inhibition of MAO-A and stimulation of behavioural activities in mice by the inactive prodrug form of the anti-influenza agent oseltamivir

Miki Hiasa; Yumiko Isoda; Yasushi Kishimoto; Kenta Saitoh; Yasuaki Kimura; Motomu Kanai; Masakatsu Shibasaki; Dai Hatakeyama; Yutaka Kirino; Takashi Kuzuhara

Oseltamivir is the most widely prescribed anti‐influenza medication. However, in rare instances, it has been reported to stimulate behavioural activities in adolescents. The goal of this study was to determine the molecular mechanism responsible for these behavioural activities.


Organic Letters | 2013

Catalytic Anomeric Aminoalkynylation of Unprotected Aldoses

Yasuaki Kimura; Soichi Ito; Yohei Shimizu; Motomu Kanai

A copper(I)-catalyzed anomeric aminoalkynylation reaction of unprotected aldoses was realized. Use of an electron-deficient phosphine ligand, boric acid to stabilize the iminium intermediate, and a protic additive (IPA) to presumably enhance reversible carbohydrate-boron complexation were all essential for efficient conversion. The reaction proceeded well even with a natural disaccharide substrate, suggesting that the developed catalytic reaction could be useful for the synthesis of glycoconjugates with minimum use of protecting groups.


ChemBioChem | 2015

Supramolecular Ligands for Histone Tails by Employing a Multivalent Display of Trisulfonated Calix[4]arenes

Yasuaki Kimura; Nae Saito; Kayo Hanada; Jiaan Liu; Takayoshi Okabe; Shigehiro A. Kawashima; Kenzo Yamatsugu; Motomu Kanai

Post‐translational modification of histone tails plays critical roles in gene regulation. Thus, molecules recognizing histone tails and controlling their epigenetic modification are desirable as biochemical tools to elucidate regulatory mechanisms. There are, however, only a few synthetic ligands that bind to histone tails with substantial affinity. We report CA2 and CA3, which exhibited sub‐micromolar affinity to histone tails (especially tails with a trimethylated lysine). Multivalent display of trisulfonated calix[4]arene was important for strong binding. CA2 was applicable not only to synthetic tail peptides but also to endogenous histone proteins, and was successfully used to pull‐down endogenous histones from nuclear extract. These findings indicate the utility of these supramolecular ligands as biochemical tools for studying chromatin regulator protein and as a targeting motif in ligand‐directed catalysis to control epigenetic modifications.


Chemical & Pharmaceutical Bulletin | 2018

Chemical Ligation Reactions of Oligonucleotides for Biological and Medicinal Applications

Hiroshi Abe; Yasuaki Kimura

Chemical ligation of oligonucleotides (ONs) is the key reaction for various ON-based technologies. We have tried to solve the problems of RNA interference (RNAi) technology by applying ON chemical ligation to RNAi. We designed a new RNAi system, called intracellular buildup RNAi (IBR-RNAi), where the RNA fragments are built up into active small-interference RNA (siRNA) in cells through a chemical ligation reaction. Using the phosphorothioate and iodoacetyl groups as reactive functional groups for the ligation, we achieved RNAi effects without inducing immune responses. Additionally, we developed a new chemical ligation for IBR-RNAi, which affords a more native-like structure in the ligated product. The new ligation method should be useful not only for IBR-RNAi but also for the chemical synthesis of biofunctional ONs.


Nucleic Acids Research | 2017

Chemical ligation of oligonucleotides using an electrophilic phosphorothioester

Hideto Maruyama; Ryota Oikawa; Mayu Hayakawa; Shono Takamori; Yasuaki Kimura; Naoko Abe; Genichiro Tsuji; Akira Matsuda; Satoshi Shuto; Yoshihiro Ito; Hiroshi Abe

Abstract We developed a new approach for chemical ligation of oligonucleotides using the electrophilic phosphorothioester (EPT) group. A nucleophilic phosphorothioate group on oligonucleotides was converted into the EPT group by treatment with Sangers reagent (1-fluoro-2,4-dinitrobenzene). EPT oligonucleotides can be isolated, stored frozen, and used for the ligation reaction. The reaction of the EPT oligonucleotide and an amino-modified oligonucleotide took place without any extra reagents at pH 7.0–8.0 at room temperature, and resulted in a ligation product with a phosphoramidate bond with a 39–85% yield. This method has potential uses in biotechnology and chemical biology.


Angewandte Chemie | 2009

A synthesis of Tamiflu by using a barium-catalyzed asymmetric Diels-Alder-type reaction.

Kenzo Yamatsugu; Liang Yin; Shin Kamijo; Yasuaki Kimura; Motomu Kanai; Masakatsu Shibasaki


Tetrahedron Letters | 2009

Design and synthesis of immobilized Tamiflu analog on resin for affinity chromatography

Yasuaki Kimura; Kenzo Yamatsugu; Motomu Kanai; Noriko Echigo; Takashi Kuzuhara; Masakatsu Shibasaki


Bulletin of The Korean Chemical Society | 2010

Design and Synthesis of Resin-Conjugated Tamiflu Analogs for Affinity Chromatography

Yasuaki Kimura; Kenzo Yamatsugu; Motomu Kanai; Noriko Echigo; Takashi Kuzuhara; Masakatsu Shibasaki


Chemical Communications | 2017

A covalent G-site inhibitor for glutathione S-transferase Pi (GSTP1-1)

Yuko Shishido; Fumiaki Tomoike; Yasuaki Kimura; Keiko Kuwata; Takato Yano; Kenji Fukui; Haruka Fujikawa; Yoshitaka Sekido; Yuko Murakami-Tonami; Tomoshi Kameda; Satoshi Shuto; Hiroshi Abe

Collaboration


Dive into the Yasuaki Kimura's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Takashi Kuzuhara

Tokushima Bunri University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge